Drug intelligence / Profile preview

tenoxicam potassium

Development stage
Preclinical
Lead developer
Jinghua Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Tenoxicam potassium salt is a potassium salt form of tenoxicam, a non-steroidal anti-inflammatory drug (NSAID) belonging to the oxicam class. Developed by Jinghua Pharmaceutical, it is primarily utilized as a pharmaceutical intermediate or refined active ingredient for the production of tenoxicam-based medications. Like the parent compound, tenoxicam potassium acts by non-selectively inhibiting the enzymes cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), thereby blocking the synthesis of prostaglandins that mediate pain, fever, and inflammation. It is indicated for the management of inflammatory and degenerative disorders of the musculoskeletal system, such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.

Other names
tenoxicam potassium salttenoxicam refined potassium salt替诺昔康精制钾化物
02

Targets

FPR1 (Formyl peptide receptor 1)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on tenoxicam potassium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tenoxicam potassium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call